Veterans Affairs banner with U.S. Flag

VA National Clinical Public Health Programs — HIV/AIDS

www.hiv.va.gov

Send to printer
< Close window

Disclaimer: This information is not meant to substitute for professional advice; please consult your medical provider or pharmacist.

Drug Dosing Toolkit

Viramune (nevirapine)

Type of Drug: Nonnucleoside Reverse Transcriptase Inhibitor
(NNRTI, nonnucleoside, "nonnuke")

Note: To reduce side effects when starting this medication, patients should take one 200 mg pill daily for the first 14 days, and then follow the schedule below.

Approved adult dosing

one 200 mg tablet, two times a day

  • Morning

    Viramune 200

    Viramune

  • Evening

    Viramune 200

    Viramune

Note: Can be taken as 2 pills once a day after the first 14 days, if prescribed by a doctor; this is not approved by the U.S. Food and Drug Administration (FDA)

My doctor's instructions

Notes on taking this medication

  • No food restrictions, can take with or without food
  • Viramune interacts with many other drugs; persons using Viramune with those drugs may need an adjustment to their dose of the other drugs or avoid certain combinations; consult your medical provider

Side effects

  • Rash: rarely, rash may be severe and may require hospitalization; rash usually appears within first 3 weeks of starting drug
  • Liver inflammation; rarely severe liver damage; liver test results should be monitored closely for the first 18 weeks that you take Viramune
  • Nausea; abdominal discomfort
^ Back to the topProviders' HomePatients' Home